$741 Million is the total value of Data Collective IV GP, LLC's 5 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Embark Trucks, Inc. | $553,091,000 | – | 63,720,154 | +100.0% | 74.67% | – | |
| RXRX | New | Recursion Pharmaceuticals, Inc. | $101,771,000 | – | 5,941,120 | +100.0% | 13.74% | – |
| New | Evolv Technologies | $47,282,000 | – | 10,601,281 | +100.0% | 6.38% | – | |
| New | Rocket Lab USA, Inc. | $35,972,000 | – | 2,929,350 | +100.0% | 4.86% | – | |
| MNMD | New | Mind Medicine (MindMed) Inc. | $2,604,000 | – | 1,505,248 | +100.0% | 0.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
| Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
| Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
| Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
| Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
| Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
| Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
| Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
| Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 4 | 2022-09-01 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.